AnaptysBio, Inc. (ANAB) Financial Statements (2023 and Earlier)

Company Profile

Business Address 10770 WATERIDGE CIRCLE, SUITE 210
SAN DIEGO, CA 92121
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments548,097393,653374,227427,082248,407
Cash and cash equivalents495,729250,456171,017113,59681,189
Short-term investments52,368143,197203,210313,486167,218
Receivables876    
Prepaid expense 200   
Other undisclosed current assets4,9032,7083,5067,1344,289
Total current assets:553,876396,561377,733434,216252,696
Noncurrent Assets
Operating lease, right-of-use asset19,558  
Property, plant and equipment2,2831,7831,6181,445665
Long-term investments and receivables67,09717,54654,30573,12875,897
Long-term investments67,09717,54654,30573,12875,897
Deposits noncurrent assets    46
Restricted cash and investments 60606060
Other noncurrent assets2566021,481148 
Total noncurrent assets:89,19419,99157,46474,78176,668
TOTAL ASSETS:643,070416,552435,197508,997329,364
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities14,59419,47927,28914,2047,198
Accounts payable1,7414,21716,2375,4432,323
Accrued liabilities12,85315,26211,0528,7614,875
Debt  1,3757,5746,875
Other liabilities 3428715817
Other undisclosed current liabilities1,505    
Total current liabilities:16,09919,82129,53521,83614,090
Noncurrent Liabilities
Long-term debt and lease obligation19,450  6257,553
Long-term debt, excluding current maturities   6257,553
Operating lease, liability19,450  
Liabilities, other than long-term debt  654171140
Accounts payable and accrued liabilities   171140
Other liabilities  654  
Total noncurrent liabilities:38,900 6547967,693
Total liabilities:54,99919,82130,18922,63221,783
Stockholders' equity
Stockholders' equity attributable to parent356,428396,731405,008486,365307,581
Common stock2827272724
Additional paid in capital678,575660,665648,669633,251393,017
Accumulated other comprehensive income (loss)(422)(4)338(223)(426)
Accumulated deficit(321,753)(263,957)(244,026)(146,690)(85,034)
Total stockholders' equity:356,428396,731405,008486,365307,581
Other undisclosed liabilities and equity231,643    
TOTAL LIABILITIES AND EQUITY:643,070416,552435,197508,997329,364

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues63,17575,0008,0005,00010,000
Revenue, net10,000
Gross profit:63,17575,0008,0005,00010,000
Operating expenses(119,989)(98,879)(115,432)(71,722)(38,781)
Operating loss:(56,814)(23,879)(107,432)(66,722)(28,781)
Nonoperating income (expense)(982)3,9489,9444,874(1,289)
Investment income, nonoperating    1,623
Other nonoperating income (expense)37(11)1(159)229
Interest and debt expense  (1,041)(1,652)(1,775)
Loss from continuing operations before equity method investments, income taxes:(57,796)(19,931)(98,529)(63,500)(31,845)
Other undisclosed income from continuing operations before income taxes  1,0411,6521,775
Loss from continuing operations before income taxes:(57,796)(19,931)(97,488)(61,848)(30,070)
Income tax benefit  152192 
Net loss available to common stockholders, diluted:(57,796)(19,931)(97,336)(61,656)(30,070)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(57,796)(19,931)(97,336)(61,656)(30,070)
Other comprehensive income (loss)   203(426)
Comprehensive loss:(57,796)(19,931)(97,336)(61,453)(30,496)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(418)(342)561  
Comprehensive loss, net of tax, attributable to parent:(58,214)(20,273)(96,775)(61,453)(30,496)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: